{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:42:26Z","timestamp":1761093746625,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bcmd.2017.05.012","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T13:32:26Z","timestamp":1495632746000},"page":"43-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Extensive ulcerated lesions in a patient with cutaneous myeloid sarcoma responded to twice-daily fludarabine and cytarabine regimen"],"prefix":"10.1016","volume":"69","author":[{"given":"Maliha","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-5181","authenticated-orcid":false,"given":"Rabbia","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2017.05.012_bb0005","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.05.012_bb0010","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0190-9622(99)70086-1","article-title":"Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria","volume":"40","author":"Kaddu","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bcmd.2017.05.012_bb0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2340\/00015555-1312","article-title":"Cutaneous myeloid sarcoma presenting as grey pigmented macules","volume":"92","author":"Niiyama","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.bcmd.2017.05.012_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2340\/00015555-1458","article-title":"Cutaneous myeloid sarcoma: natural history and biology of an uncommon manifestation of acute myeloid leukemia","volume":"93","author":"Hurley","year":"2013","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.bcmd.2017.05.012_bb0025","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/cup.12231","article-title":"Aleukemic cutaneous myeloid sarcoma","volume":"40","author":"Aboutalebi","year":"2013","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.bcmd.2017.05.012_bb0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clml.2012.03.003","article-title":"Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed\/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast-phase chronic myeloid leukemia","volume":"12","author":"Jabbour","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979617302140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979617302140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:34:30Z","timestamp":1761050070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979617302140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":6,"alternative-id":["S1079979617302140"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.05.012","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extensive ulcerated lesions in a patient with cutaneous myeloid sarcoma responded to twice-daily fludarabine and cytarabine regimen","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}